🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of TENS on Pain and Symptoms in Primary Dysmenorrhea

RecruitingNAAges 18 Years - anyFemaleOsmaniye Korkut Ata University
NCT06741059 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The Effect of Transcutaneous Electrical Nerve Stimulation (TENS) on Pain and Menstrual Symptoms in Primary Dysmenorrhea This study aims to investigate the effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) in managing pain and alleviating menstrual symptoms in individuals with primary dysmenorrhea. Primary dysmenorrhea is characterized by severe menstrual pain and accompanying symptoms that negatively impact the quality of life and daily functioning. TENS, a non-invasive and drug-free method, is applied to relieve pain by stimulating nerves through electrical impulses. This research evaluates the impact of TENS on both the intensity of menstrual pain and associated symptoms, offering insights into its potential as an alternative or complementary therapeutic approach.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Aged 18 and above * Have regular menstrual cycles (lasting 3 to 8 days, with a menstrual cycle range of 21 to 35 days) * Have dysmenorrhea pain severity rated 4 or higher on the Visual Analog Scale (VAS) Exclusion Criteria: Women with the following conditions were excluded from the study: * Secondary dysmenorrhea * Using oral contraceptives * Having impaired tissue integrity in the abdominal area * Having previous experience with TENS * Having a history of nerve damage or sensory loss * Having a pacemaker * Having any systemic diseases * Being pregnant or in the postpartum period
💊

What it tests

  • Transkutanöz Elektriksel Sinir Stimülasyonu - TENS
📍

Where

1 site
Esra Ünal
Osmaniye, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy